IL2 and autoimmune disease: It is well known that IL‐2, through its receptor CD25, is involved in the generation, maturation, and function of Tregs, and a low dose of IL‐2 showed promise as a therapeutic agent in inflammatory and autoimmune diseases, including hepatitis C virus‐induced vasculitis [68, 69, 70].